12 hospitals sign up for Covid vaccine trials

At least 12 hospitals in the country, in addition to the Philippine General Hospital, will be decided as sites for the World Health Organization (WHO) clinical trial of candidate vaccines for coronavirus disease 2019 (Covid-19).

Scientific and technological Secretary Fortunato de los angeles Pea. Photo DOST

At the media forum organized through the Ministry of Health (DoH) on Friday, the Secretary of Science and Technology Fortunato de los Angeles Pea said that outside the hospital sites, another 8 spaces of the country would be selected for rehearsal.

Five of these spaces are in the Metropolitan Area of Manila, one in Calabarzon (Cavite, Laguna, Batangas, Rizal and Quezon), one in Cebu and one in Davao.

De los angeles Pea stated that zoning ensured that only one clinical trial would be organized in the area.

Potential participants in the solidarity test will come from the top five or 10 barangays (villages) with a higher number of Covid-19 instances depending on their attack rates of 1,000 inhabitants.

“Because we need to verify the effectiveness of the vaccine, and we will do it in stages when the rate of occurrence or attack is high,” Pea said of the angels.

In addition to the solidarity trial, independent trials can also take plos angelescente in by-default areas, Pea angels said.

Seventeen vaccine brands have signed agreements with the Philippines for their products here.

Six of them, the Gamaleya Research Institute of Russia; Sinovac Biotech Ltd. , Sinopharm Group Co. Ltd. et ZFSW Biotech of China; Adimmune Corp. Taiwan; and laboratories at the University of Queensland-CSL of Australia are about to sign confidentiality agreements.

De los angeles Pea said the vaccine organization tracks several trials that were suspended for protective reasons.

Food and Drug Administration (FDA) executive leader Rolando Enrique Domingo said clinical trials could be completed until the end of the year at the latest, with a registration application imaginable in the first quarter of next year.

If the trials are completed in December or January and a corporate file with the FDA, “then it is imaginable that in April 2021 we have an approved vaccine,” Domingo said.

He suggested that local governments begin their own clinical trials after Governor Juane Juanito “Jonvic” Remulla announced his goal of conducting trials for 10,000 residents.

“It is allowed . . . we have very strict protocols for human trials, especially for a vaccine that doesn’t yet exist,” Domingo said.

Similarly, the government now requires patients with asymptomatic and mild coronavirus whose homes meet home quarantine needs to be remote in institutions.

In a statement, Palace spokesman Harry Roque Jr. said the Interagency Working Group on the Management of Emerging Infectious Diseases (IATF-EID) had the directive after its assembly on Thursday.

Vulnerable or comorbid patients through a local fitness employee and whose homes meet the isolation needs of the house of the Department of Health and the Ministry of the Interior and the Local Government are excluded from the directive.

“Your exception would be when Ligtas Covid-19 centers in the region are fully occupied and the local government unit has enough isolation facilities,” he added.

In July, IATF-EID required soft, asymptomatic instances of Covid-19 to be remote in quarantine facilities, especially if they have their own bedroom and bathroom.

Interior Secretary Eduardo Ao had proposed banning home quarantine for coronavirus patients.

There are 4 We Heal As One centers in Metro Manila and two in Clark, Pampanga.

These services are the Ninoy Aquino Stadium and rizal Memorial Stadium of the Rizal Memorial Sports Complex; Forum Rooms of the International Convention Center of the Philippines and World Trade Center of Pasay City; The Asean Convention Center in Clark, Pampanga; and the National Government Administrative Center in New Clark City, Capas, Tarlac.

As of Friday, there were 296,755 covid, 5,127 deaths from the virus and 231,928 cures.

You have effectively joined our subscriber list.

 

Leave a Comment

Your email address will not be published. Required fields are marked *